Safcak D, Drazilova S, Gazda J, Andrasina I, Adamcova-Selcanova S, Barila R, et al. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort. Journal of Clinical Medicine. 2021;10(14).

Zemanova M, Cernovska M, Havel L, Bartek T, Lukesova S, Jakesova J, et al. Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial. Cancer Treatment and Research Communications. 2021;28.

Tokarčík J, Slížová D, Andrašina I, Šafčák D, Rudnay M, Demková K. Occurrence of two histopathologically different malignancies. Klinicka onkologie. 2021;

Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, et al. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. The Lancet Oncology. 2021;22(1):51-65.

Kacírová M, Bober P, Alexovič M, Tomková Z, Tkáčiková S, Talian I, et al. Differential Urinary Proteomic Analysis of Endometrial Cancer. Physiological Research.;:S483-S490.

LISPER - The intergrative strategy in personalized medicine developement of cancer and it´s influence on qualitiy of live

(313011V446)